by delphic-admin | Jun 19, 2024 | APAC
China’s Center for Drug Revaluation and National Center for Adverse Drug Reaction (ADR) Monitoring have issued final guidelines for reporting adverse reactions to cosmetics. The Guidelines for the Collection and Reporting of Adverse Reactions of Cosmetics by...
by delphic-admin | May 29, 2024 | APAC
China’s National Institutes for Food and Drug Control (NIFDC) published on 10 April six draft technical guidelines to support cosmetic safety assessments under the overarching Cosmetics Supervision and Administration Regulations (CSAR). Two of the guidelines are...
by delphic-admin | May 29, 2024 | APAC
The National Medicinal Products Administration (NMPA) has just announced a series of optimisations on the management of cosmetic safety assessments in China. The major adjustments include: a) Classification on cosmetic...
by delphic-admin | Apr 18, 2024 | APAC
China’s National Medical Products Administration (NMPA) has revised the country’s Cosmetic Safety Technical Guidelines (STSC) in a notice published on 21 March. Eleven test methods have been approved by the Expert Committee on Cosmetics Standards and are now included...
by delphic-admin | Apr 18, 2024 | APAC
China’s National Institutes for Food and Drug Control (NIFDC) is consulting on two draft guidance documents outlining how to complete cosmetic safety assessments under the Cosmetics Supervision and Administration Regulations (CSAR). The NIFDC said the documents are...
